Mycobacterial infection-related morbidity and mortality in patients following cardiopulmonary bypass surgery is high and there is a growing need for a consensus-based expert opinion to provide international guidance for diagnosing, preventing and treating in these patients. In this document the International Society for Cardiovascular Infectious Diseases (ISCVID) covers aspects of prevention (field of hospital epidemiology), clinical management (infectious disease specialists, cardiac surgeons, ophthalmologists, others), laboratory diagnostics (microbiologists, molecular diagnostics), device management (perfusionists, cardiac surgeons) and public health aspects.

• MeSH
• Anti-Bacterial Agents therapeutic use   MeSH
• Mycobacterium Infections, Nontuberculous * diagnosis   drug therapy   prevention & control   MeSH
• Cross Infection * diagnosis   drug therapy   microbiology   prevention & control   MeSH
• Communicable Diseases MeSH
• Cardiac Surgical Procedures adverse effects   methods   MeSH
• Cardiology MeSH
• Cardiopulmonary Bypass MeSH
• Equipment Contamination MeSH
• Humans MeSH
• Mycobacterium * isolation & purification   MeSH
• Risk Factors MeSH
• Societies, Medical MeSH
• Check Tag
• Humans MeSH
• Publication type
• Journal Article MeSH
• Practice Guideline MeSH
• Geographicals
• United Kingdom MeSH